ATS 2019 Virtual Final Program

BEHAVIORAL • CLINICAL SCIENTIFIC SYMPOSIUM CME Credits Available: 2 B88 MIGRANT AND REFUGEE MEDICINE: IMPLICATIONS FOR PULMONARY AND CRITICAL CARE CLINICIANS Assembly on Behavioral Science and Health Services Research 2:15 p.m. - 4:15 p.m. KBHCCD Room D167/D174 (Level 1) Target Audience All pulmonary care professionals who treat migrant/refugee patients;clinicians interested in migrant and refugee issues both domestically and internationally; providers working in the field of migrant and refugee health Objectives At the conclusion of this session, the participant will be able to: • understand the global migrant crisis and the unique health challenges faced by the migrant and refugee populations; • understand the cultural, legal and political implications of providing clinical care for refugees and migrants; • develop an understanding of the clinician’s role in the larger national and international debates on immigration. This session provides an evidence based, interprofessional lens into topics related to migrant and refugee health. It highlights the clinical, political and medicolegal aspects of the migrant and refugee crisis both locally and globally. By attending this session, pulmonary, critical care and sleep professionals will learn how to provide culturally sensitive, multidisciplinary, patient-centered care to this ever growing vulnerable patient population. Chairing: A. Papali, MD,CM, Charlotte, NC M. Eakin, PhD, Baltimore, MD 2:15 Respiratory Health Implications of the Global Migrant Crisis D.J. Upson, MD, MA, Albuquerque, NM 2:35 Providing Medical Care to Displaced Populations: A Pulmonologist’s Perspective A. Elahi, MD, Charlotte, NC 2:55 “I Am Alone in This World”: Impact of Trauma in Refugees M. Eakin, PhD, Baltimore, MD 3:15 Occupational Health and Safety of Immigrant Workers M.B. Schenker, MD, MPH, Davis, CA 3:35 Migrant Health: What Is the Role of PAHO and the WHO? F.C. Becerra, MD, MPH, DrPH, Washington, D.C. 3:55 The New Mexico Approach to Border Migrant Health A. Achrekar, MD, MPH, Santa Fe, NM BEHAVIORAL • CLINICAL SCIENTIFIC SYMPOSIUM CME Credits Available: 2 B89 CHALLENGES IN CONDUCTING AND INTERPRETING ARDS AND SEPSIS RANDOMIZED CLINICAL TRIALS Assemblies on Critical Care; Behavioral Science and Health Services Research; Nursing; Pediatrics 2:15 p.m. - 4:15 p.m. OMNI DALLAS DOWNTOWN Dallas Ballroom A-C (Level 3) Target Audience Adult and pediatric critical care clinicians and trialists, nurses, research coordinators Objectives At the conclusion of this session, the participant will be able to: • identify challenges in conducting and interpreting randomized controlled trials among a critically ill population; • review current literature and future directions for innovative strategies for overcoming the challenges in conducting and interpreting randomized controlled trials among a critically ill population; • understand the patient and surrogate perspectives of participating in randomized controlled trials while critically ill. This session will present the challenges of conducting randomized controlled trials in critical care. Specifically challenges of recruitment, retention and generalizability and how they may contribute to the paucity of proven efficacious interventions in the ICU. By using recent examples of critical care trials, this session will also appeal to clinicians who seek greater insight on interpreting and applying literature to their patients. We will explore established and emerging research addressing strategies to overcome challenges in ICU randomized controlled trials. Chairing: D. Krutsinger, MD, Philadelphia, PA R.D. Stapleton, MD, PhD, ATSF, Burlington, VT M.N. Gong, MS, MD, Bronx, NY 2:15 My Story: What Is It like to Be in an ICU Trial? E. Rubin, JD, Northbrook, IL 2:27 Perspectives of Surrogate Decision Makers and a Nudge Towards Participation in Critical Care Trials D. Krutsinger, MD, Philadelphia, PA 2:45 Retention in Longitudinal Critical Care Trials D.M. Needham, MD, PhD, Baltimore, MD 3:03 Lessons Learned From Special Issues in Pediatric Critical Care Trials M.A.Q. Curley, PhD, RN, Philadelphia, PA 3:21 Personalized Medicine or Big Tent? Issues of Generalizability A. Deane, MBBS, PhD, Melbourne, Australia 3:39 The Power of Clinical Trial Networks and How You Can Be Involved K. Burns, MD, MSCR, Toronto, Canada 3:57 Evolution of Modern Critical Care Trials: From the Past to Future C.W. Seymour, MD, MSc, Pittsburgh, PA ATS 2019 • Dallas, TX 202 MONDAY • MAY 20